EP Patent

EP1472250B1 — Neue anticholinergika, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2014-11-26 · 11y expired

What this patent protects

Patent listed against Ecclock.

Drugs covered by this patent

Patent Metadata

Patent number
EP1472250B1
Jurisdiction
EP
Classification
—
Expires
2014-11-26
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.